Sort
15,842 grants matching “pancreatic cancer”
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents
$277,258Ana M Navarro · University Of California, San Diego · U54 · FY2011 · CA
Core 1: Biospecimen and Pathology Core
$277,212Dipen M. Maru · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Systemic Nanocurcumin for Pancreatic Cancer Therapy
$277,188Anirban Maitra · Johns Hopkins University · U54 · FY2012 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$277,001Andrew M Lowy · University Of California, San Diego · R01 · FY2012 · CA
Signaling Pathways Regulating Epithelial Cell Survival
$276,784Paul Dent · Virginia Commonwealth University · R01 · FY2013 · DK
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents
$276,783Ana M Navarro · University Of California, San Diego · U54 · FY2012 · CA
Alcohol Consumption & Mortality in the US 1950-2000
$276,713William C Kerr · Public Health Institute · R01 · FY2007 · AA
Biomedical Computing Tools for Pancreatic Can. Res. - Evanston NW H. consortium
$276,691Randall Brand · University Of Nebraska Medical Center · R33 · FY2007 · CA
Enhanced CRAd for Pancreatic Cancer
$276,500Masato Yamamoto · University Of Minnesota · R56 · FY2007 · CA
Genetic Mechanisms in Experimental Pancreatic Cancer
$276,335University Of Wisconsin Madison · R01 · FY2005 · CA
GLYCOCONJUGATES IN PANCREATIC CANCER
$276,304Northern California Institute Res &Educ · R01 · FY2002 · CA
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
$276,298Vladimir Bogdanov · University Of Cincinnati · R01 · FY2017 · CA
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
$276,298Vladimir Bogdanov · University Of Cincinnati · R01 · FY2018 · CA
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
$276,298Vladimir Bogdanov · University Of Cincinnati · R01 · FY2016 · CA
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
$276,202Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2014 · CA
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$276,098Donald K Scott · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · DK
Administrative Core
$275,946Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2025 · CA
The Role of Alternative RNA Splicing on Endothelial Cell Barrier Dysfunction in Acute Respiratory Distress Syndrome
$275,881Sean Farrell Monaghan · Ocean State Research Institute, Inc. · P20 · FY2020 · GM
Implantable Electrospun Cell Chamber Device with Immune-Evasive Properties for Beta Cell Replacement Therapy
$275,766Patrick J Hayden · Biosurfaces · R43 · FY2023 · DK
The role of p16INK4a in mammalian aging
$275,765Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2007 · AG
Functional analysis of MEN1 in Drosophila model
$275,759Yale University · R01 · FY2002 · GM
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
$275,645Lyla Stanland · Enfuego Therapeutics Inc. · R44 · FY2023 · CA
Applications of "Recombomice" for Cancer Research
$275,644Bevin P. Engelward · Massachusetts Institute Of Technology · R33 · FY2006 · CA
Nucleoside Transporter-Connexin Interplay in Pancreatic Cancer Chemotherapy
$275,639Rajgopal Govindarajan · University Of Georgia · R15 · FY2014 · CA
METABOLIC ENGINEERING OF REACTIVE GLYCOCONJUGATES
$275,634University Of California Berkeley · R01 · FY2004 · GM